PCN212 ECONOMIC EVALUATION OF TOPOTECAN IN COMPARISON WITH PEGYLATED LIPOSOMAL DOXORUBICIN IN THE TREATMENT OF RECURRENT OVARIAN CANCER IN IRAN
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.408
https://www.valueinhealthjournal.com/article/S1098-3015(19)32786-X/fulltext
Section Title :
Section Order :
10337
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32786-X&doi=10.1016/j.jval.2019.09.408